Nov 05, 2015 1:58pm EST OPKO to Announce Third Quarter Operating and Financial Results on November 9, 2015
Nov 05, 2015 8:30am EST Additional Phase 3 Data Supporting OPKO’s Rayaldee as a Treatment for Secondary Hyperparathyroidism in Chronic Kidney Disease to be Presented at Kidney Week 2015
Oct 21, 2015 11:30pm EDT OPKO Health’s GeneDx business Presenting at National Society of Genetic Counselors Annual Meeting
Oct 13, 2015 8:00am EDT Vanderbilt University School of Medicine and OPKO Health Collaborate on Genomics
Oct 08, 2015 8:30am EDT OPKO to Host Symposium to Present Clinical Data on its Long-acting Human Growth Hormone at the 49th Annual Meeting of the Japanese Society for Pediatric Endocrinology
Oct 07, 2015 9:32am EDT OPKO Presents Clinical Data on its Long-acting Human Growth Hormone (hGH-CTP) in Two Oral Presentations at the 54th Annual Meeting of the European Society for Pediatric Endocrinology (ESPE)